Case Reports

Incidentally Discovered Ochronosis Explaining Decades of Chronic Pain

Author and Disclosure Information

 

References

Conclusion

Alkaptonuria is a rare autosomal recessive metabolic disorder that has a progressively debilitating pathophysiologic course spanning decades of a patient’s life. Its low prevalence and gradually progressive nature make it a difficult diagnosis to make without clinical suspicion. In patients with early-onset degenerative joint disease, tendinopathy, and cartilage or skin discoloration, congenital metabolic disorders like alkaptonuria should be considered.

As this case shows, suspicion and diagnosis can occur during surgical intervention in which tendon discoloration is directly visualized, especially in patients without prominent skin or cartilage discoloration. Once the diagnosis is made through elevated levels of urine HGA, there are 3 management strategies, including decreasing homogentisic acid buildup, providing symptom management, and monitoring for arthropathic, CV, and genitourinary complications.

Pages

Recommended Reading

FDA approves afamelanotide for treatment of rare condition with light-induced pain
Federal Practitioner
Drug crisis continues to evolve beyond opioids
Federal Practitioner
Is carpal tunnel syndrome the tip of the iceberg?
Federal Practitioner
Opioids, benzodiazepines carry greater risk of COPD-related hospitalization
Federal Practitioner
Adiposis Dolorosa Pain Management
Federal Practitioner
Cancer pain management inadequate in opioid-saturated areas
Federal Practitioner
Support for medical marijuana transcends political affiliation
Federal Practitioner
Depression linked to persistent opioid use after hysterectomy
Federal Practitioner
Survey: Cancer-related pain, opioid use up since 2018
Federal Practitioner
In addiction, abusive partners can wreak havoc
Federal Practitioner

Related Articles